Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 28

    1.

    Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.

    Nguyen T, Vacek PM, O'Neill P, Colletti RB, Finette BA.

    Cancer Res. 2009 Sep 1;69(17):7004-12. Epub 2009 Aug 25.PMID: 19706768 [PubMed - indexed for MEDLINE]Related articles

    2.

    Induction of V(D)J-mediated recombination of an extrachromosomal substrate following exposure to DNA-damaging agents.

    Pinsonneault RL, Vacek PM, O'Neill JP, Finette BA.

    Environ Mol Mutagen. 2007 Jul;48(6):440-50.PMID: 17584881 [PubMed - indexed for MEDLINE]Related articles

    3.

    V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.

    Murray JM, O'Neill JP, Messier T, Rivers J, Walker VE, McGonagle B, Trombley L, Cowell LG, Kelsoe G, McBlane F, Finette BA.

    J Immunol. 2006 Oct 15;177(8):5393-404.PMID: 17015725 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.

    Kendall HE, Vacek PM, Rivers JL, Rice SC, Messier TL, Finette BA.

    Cancer Res. 2006 Sep 1;66(17):8455-61.PMID: 16951156 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.

    Messier TL, O'Neill JP, Finette BA.

    Hum Mutat. 2006 Aug;27(8):829.PMID: 16835902 [PubMed - indexed for MEDLINE]Related articles

    6.

    Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.

    Finette BA.

    DNA Repair (Amst). 2006 Sep 8;5(9-10):1049-64. Epub 2006 Jun 27. Review.PMID: 16807138 [PubMed - indexed for MEDLINE]Related articles

    7.

    Somatic mutant frequency at the HPRT locus in children associated with a pediatric cancer cluster linked to exposure to two superfund sites.

    Vacek PM, Messier T, Rivers J, Sullivan L, O'Neill JP, Finette BA.

    Environ Mol Mutagen. 2005 May;45(4):339-45.PMID: 15657919 [PubMed - indexed for MEDLINE]Related articles

    8.

    Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.

    Kendall HE, Vacek PM, Finette BA.

    Mutagenesis. 2004 Sep;19(5):409-12.PMID: 15388815 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.

    Rice SC, Vacek P, Homans AH, Messier T, Rivers J, Kendall H, Finette BA.

    Cancer Res. 2004 Jul 1;64(13):4464-71.PMID: 15231655 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparative analysis of HPRT mutant frequency in children with cancer.

    Rice SC, Vacek PM, Homans AH, Kendall H, Rivers J, Messier T, Finette BA.

    Environ Mol Mutagen. 2003;42(1):44-9.PMID: 12874812 [PubMed - indexed for MEDLINE]Related articles

    11.

    In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.

    Messier TL, O'Neill JP, Hou SM, Nicklas JA, Finette BA.

    EMBO J. 2003 Mar 17;22(6):1381-8.PMID: 12628930 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mutational spectral analysis at the HPRT locus in healthy children.

    Finette BA, Kendall H, Vacek PM.

    Mutat Res. 2002 Aug 29;505(1-2):27-41.PMID: 12175903 [PubMed - indexed for MEDLINE]Related articles

    13.

    Accumulation of somatic mutations in proliferating T cell clones from children treated for leukemia.

    Finette BA, Homans AC, Rivers J, Messier T, Albertini RJ.

    Leukemia. 2001 Dec;15(12):1898-905.PMID: 11753611 [PubMed - indexed for MEDLINE]Related articles

    14.

    Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.

    Yoshioka M, O'Neill JP, Vacek PM, Finette BA.

    Cancer Res. 2001 Apr 15;61(8):3432-8.PMID: 11309304 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Distinguishing potential sources of genotoxic exposure via HPRT mutations.

    Molholt B, Finette BA.

    Radiats Biol Radioecol. 2000 Sep-Oct;40(5):529-34.PMID: 11130945 [PubMed - indexed for MEDLINE]Related articles

    16.

    Emergence of genetic instability in children treated for leukemia.

    Finette BA, Homans AC, Albertini RJ.

    Science. 2000 Apr 21;288(5465):514-7.PMID: 10775110 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT.

    Sussman HE, Olivero OA, Meng Q, Pietras SM, Poirier MC, O'Neill JP, Finette BA, Bauer MJ, Walker VE.

    Mutat Res. 1999 Oct 19;429(2):249-59.PMID: 10526209 [PubMed - indexed for MEDLINE]Related articles

    19.

    Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.

    Yoshioka M, Vacek PM, Poseno T, Silver R, Finette BA.

    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):586-91.PMID: 9892677 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Transition mutations at CpG dinucleotides are the most frequent in vivo spontaneous single-based substitution mutation in the human HPRT gene.

    O'Neill JP, Finette BA.

    Environ Mol Mutagen. 1998;32(2):188-91. Review. No abstract available. PMID: 9776183 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...